Aberrant expression/activation of PAK1 has been described in breast cancer as well as among several other cancers including brain, pancreas, colon, bladder, ovarian, hepatocellular, urinary tract, renal cell carcinoma, and thyroid cancers (for review [12]). The gene discussed is PAK1; the disease is breast carcinoma.